IMGN - AbbVie Q4 in focus as Humira patent cliff reaches one-year mark
2024-02-01 12:10:01 ET
More on AbbVie
- AbbVie Q4 Earnings Preview: Few Clouds On Horizon Thanks To Masterful Management (Rating Upgrade)
- AbbVie Inc. (ABBV) JPMorgan 42nd Annual Healthcare Conference
- AbbVie: Still Expensive Despite The Great M&A Acumen
- AbbVie raised to Outperform at William Blair ahead of earnings
- Big Pharma earnings season in spotlight amid positive sentiment